Lee, Seulki,Pomper, Martin G.,Park, Ogyi,Swierczewska, Magdalena,Pasricha, Pankaj J.
申请号：
AU2017248264
公开号：
AU2017248264A1
申请日:
2017.04.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Death receptor 5 (DR5) agonist compositions and methods for treating pancreatitis have been developed. The compositions include Tumor Necrosis Factor-related apoptosis-inducing ligand (TRAIL), its analogues, and anti-DR5 agonistic antibodies. In certain embodiments, TRAIL analogs and anti-death receptor 5 agonistic antibodies have analgesic and disease modifying effects on the pancreas.
